Aspen Aerogels (NYSE:ASPN) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Aspen Aerogels (NYSE:ASPN) to a sell rating in a research note published on Wednesday morning.

Several other analysts have also weighed in on the company. HC Wainwright restated a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. Piper Sandler reduced their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Roth Mkm lowered their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. TD Cowen increased their target price on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research note on Tuesday, August 20th. Finally, Barclays reduced their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $28.70.

Aspen Aerogels Stock Performance

ASPN opened at $14.28 on Wednesday. The business has a 50 day moving average price of $22.04 and a two-hundred day moving average price of $24.59. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.82. The company has a market capitalization of $1.17 billion, a price-to-earnings ratio of 1,429.43 and a beta of 2.21. Aspen Aerogels has a 1-year low of $9.89 and a 1-year high of $33.15.

Insider Activity

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This trade represents a 60.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. This represents a 11.58 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.

Institutional Trading of Aspen Aerogels

Hedge funds and other institutional investors have recently modified their holdings of the company. BNP Paribas Financial Markets increased its position in Aspen Aerogels by 85.2% in the 1st quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock worth $452,000 after purchasing an additional 11,823 shares during the last quarter. Oppenheimer & Co. Inc. bought a new stake in shares of Aspen Aerogels in the 1st quarter valued at approximately $388,000. Swiss National Bank increased its holdings in Aspen Aerogels by 16.2% in the first quarter. Swiss National Bank now owns 120,500 shares of the construction company’s stock worth $2,121,000 after buying an additional 16,800 shares during the last quarter. Vanguard Group Inc. raised its position in Aspen Aerogels by 5.1% during the first quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after acquiring an additional 175,906 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new position in Aspen Aerogels during the first quarter valued at approximately $851,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.